We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAG icon
351
STAG Industrial
STAG
$7.44B
$119K ﹤0.01%
3,290
-161
-5% -$5.57K
ALKS icon
352
Alkermes
ALKS
$8.11B
$119K ﹤0.01%
4,143
GPRE icon
353
Green Plains
GPRE
$1.15B
$114K ﹤0.01%
18,830
-841
-4% -$3.71K
FR icon
354
First Industrial Realty Trust
FR
$8.66B
$112K ﹤0.01%
2,335
-172
-7% -$8.38K
EGY icon
355
Vaalco Energy
EGY
$562M
$110K ﹤0.01%
30,607
-440
-1% -$1.53K
EPRT icon
356
Essential Properties Realty Trust
EPRT
$6.92B
$110K ﹤0.01%
3,457
+136
+4% +$4.34K
ADMA icon
357
ADMA Biologics
ADMA
$2.02B
$110K ﹤0.01%
6,053
VNO icon
358
Vornado Realty Trust
VNO
$7.65B
$110K ﹤0.01%
2,878
-191
-6% -$7.15K
GEV icon
359
GE Vernova
GEV
$240B
$110K ﹤0.01%
207
-1,561
-88% -$650K
CLNE icon
360
Clean Energy Fuels
CLNE
$416M
$106K ﹤0.01%
54,463
-992
-2% -$1.69K
PCVX icon
361
Vaxcyte
PCVX
$7.65B
$104K ﹤0.01%
3,192
AHR icon
362
American Healthcare REIT
AHR
$11.1B
$103K ﹤0.01%
2,799
-100
-3% -$3.32K
TRNO icon
363
Terreno Realty
TRNO
$7.58B
$102K ﹤0.01%
1,817
-72
-4% -$4.12K
CTRE icon
364
CareTrust REIT
CTRE
$10B
$101K ﹤0.01%
3,310
-238
-7% -$6.86K
KRYS icon
365
Krystal Biotech
KRYS
$10.7B
$101K ﹤0.01%
736
CYTK icon
366
Cytokinetics
CYTK
$10.6B
$99.8K ﹤0.01%
3,021
RYTM icon
367
Rhythm Pharmaceuticals
RYTM
$7.31B
$99.4K ﹤0.01%
1,573
RHP icon
368
Ryman Hospitality Properties
RHP
$8.56B
$99.2K ﹤0.01%
1,005
-73
-7% -$6.82K
PTCT icon
369
PTC Therapeutics
PTCT
$6.18B
$96.4K ﹤0.01%
1,974
AKRO
370
DELISTED
Akero Therapeutics
AKRO
$95.4K ﹤0.01%
1,787
HR icon
371
Healthcare Realty
HR
$7.56B
$93.3K ﹤0.01%
5,882
-495
-8% -$7.53K
MRUS
372
DELISTED
Merus
MRUS
$92.2K ﹤0.01%
1,753
ACAD icon
373
Acadia Pharmaceuticals
ACAD
$4.51B
$91.9K ﹤0.01%
4,260
ACLX
374
DELISTED
Arcellx
ACLX
$91.1K ﹤0.01%
1,384
SWTX
375
DELISTED
SpringWorks Therapeutics
SWTX
$89.5K ﹤0.01%
1,905

Similar funds

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.